Document Detail

Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: a nemesis of platelet glycoprotein IIb/IIIa inhibitors.
MedLine Citation:
PMID:  10642769     Owner:  NLM     Status:  MEDLINE    
We describe three patients who developed severe pulmonary hemorrhage following administration of tirofiban (one patient) and abciximab (two patients). Pulmonary hemorrhage associated with abciximab use has been described, but to the best of our knowledge there has been no previous reports of this complication with tirofiban. Cathet. Cardiovasc. Intervent. 49:181-184, 2000.
A Ali; S Patil; K J Grady; T L Schreiber
Related Documents :
11237979 - Bleeding complications after basilar artery fibrinolysis with tissue plasminogen activa...
896039 - Computed tomography and subarachnoid hemorrhage.
7420169 - Cerebrovascular reactivity to noradrenaline and serotonin following experimental subara...
7102399 - Extensive evacuation of subarachnoid clot for prevention of vasospasm--effective or not?
16094149 - Aneurysmal rupture without subarachnoid hemorrhage: case series and literature review.
3895589 - Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
8121559 - Reconstruction of previously ligated external carotid arteries for cranial base arterio...
1636029 - Technical advances in transjugular intrahepatic portosystemic shunts.
17848399 - Reconstruction of the right atrium with pulmonary artery homograft after resection of r...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  49     ISSN:  1522-1946     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-03-01     Completed Date:  2000-03-01     Revised Date:  2013-05-24    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  181-4     Citation Subset:  IM    
Copyright Information:
Copyright 2000 Wiley-Liss, Inc.
Department of Cardiology, St. John Hospital and Medical Center, Detroit, Michigan 48236, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal / adverse effects*
Fatal Outcome
Hemoptysis / chemically induced*
Immunoglobulin Fab Fragments / adverse effects*
Myocardial Ischemia / therapy
Platelet Aggregation Inhibitors / adverse effects*
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
Pulmonary Alveoli
Thrombosis / prevention & control
Tyrosine / adverse effects,  analogs & derivatives*
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Immunoglobulin Fab Fragments; 0/Platelet Aggregation Inhibitors; 0/Platelet Glycoprotein GPIIb-IIIa Complex; 144494-65-5/tirofiban; 55520-40-6/Tyrosine; X85G7936GV/abciximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment.
Next Document:  Cerebral arterial air embolism treated by a vertical head-down maneuver.